Patient Assessment, Special Populations, and Polypharmacy Flashcards

1
Q

What are some barriers that could impact how a patient is able to communicate with a health professional?

A

Hearing loss
Decreased vision
Speech production problems
Cognitive/memory issues
Language/cultural diversity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can help when a patient needs assistance with communication?

A

Hearing aids
Assistive listening devices
Interpreter
Family member/caregiver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is history that is relevant to audiology for adults?

A

History of ear surgeries and trauma/concussion
History of recent hospitalizations
Drug history including all OTC medications
History of specific diseases (diabetes, HBP or LBP, bleeding disorders, strokes, history of tumors requiring chemo or radiation, and mental health conditions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is history that is relevant to audiology for children?

A

History of pregnancy, birth, and delivery
History of medications used, including medications used by mother during and right after pregnancy
Results of newborn hearing screening
Academic and developmental history including language
Otitis media and upper respiratory tract infections
Infectious diseases such as CMV, Zika, measles, and meningitis
History of ear surgeries, hospitalizations, trauma, & concussion
History of tumors requiring chemotherapy and/or radiation
Academic history
Family history of genetic and hearing/vestibular disorders
Social history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the privacy rule of HIPAA?

A

Permit disclosure of health information needed for patient care and other important purposes - who can you share that information with

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the security rule of HIPAA?

A

A series of administrative, physical, and technical safeguards for covered entities and their business associates to assure the confidentiality, integrity, and availability of electronic protected health information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why is reviewing drug history with a patient critical?

A

There are many patient factors that can affect drug metabolism and adverse drug reactions (which can result in ototoxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some factors for adverse drug reactions?

A

Age
Pregnancy and lactation
Diet and environment
Diseases
Preexisting auditory (SNHL) and vestibular disorders
Pharmacogenomics
Metabolic drug interactions (polypharmacy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are many biotransformations slow in young children and elderly?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Are neonates able to carry out the phases of the drug cycle?

A

They can carry out most of phase 1 reactions in the liver
Both phase 1 and 2 enzyme systems mature gradually over the first 2 weeks of life and throughout childhood
Insufficiency of the phase I and II enzymes can quickly lead to toxic levels of drugs in neonates and younger children

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Do children have increased skin and mucous membrane permeability?

A

Yes
They absorb medication more quickly and readily than adults
Leads to quicker toxic drug levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is pediatric drug dose calculated?

A

By a child’s weight
To avoid size differences and prematurity
Typically, the pediatric drug dose is half that of the adult dose, but proper pediatric doses should be calculated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why must you be careful prescribing drugs to elderly?

A

There is a general decrease in metabolic capacity due to age-related changes in liver mass, hepatic blood flow, hepatic enzyme activity (aging appears to affect the P450 (cyp) enzymes preferentially)
Alternate metabolic pathways including those involving phase II enzymes are spared with aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How might drug doses be altered for elderly?

A

They might be lowered
High doses often contribute to CNS side effects (dizziness/falls, disorientation/cognitive decline, drowsiness)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the primary concern for drugs during pregnancy?

A

Teratogenicity and side effects
Ideally, no drug should be given during pregnancy
The placental barrier is not strong for most drugs
Highest risk to the fetus is during the first trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the primary concern for drugs during lactation?

A

Whether the drug will enter breast milk and be transferred to the infant
Drug amounts in breast milk is ~ 1 to 2% of the maternal dose
Most drugs delivered through breast milk are of limited significance for the infant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some drug contraindications during lactation?

A

Lithium (e.g., treatment for bipolar disorders)
A majority of chemotherapeutic agents
Radioactive pharmaceuticals (e.g., radioactive drugs used in medical imaging such as radioactive iodine to diagnose/treat thyroid problems)
Several classes of antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Can diet and environment affect drug metabolism?

A

Yes
Can inhibit or induce cytochrome P450 (CYP) enzyme in the liver
Grapefruit juice, contains chemicals that inhibit the CYP3A4 enzyme in the small intestine and decreases phase 1 metabolism (important when taking drugs like calcium-channel blockers (hypertension) and statins (cholesterol))
Grapefruit juice in higher doses will decrease metabolism and lead to high plasma levels of these drug causing potential
Liver damage
Rhabdomyolysis – rare (severe muscle damage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where are endogenous substances used in phase II derived from?

A

The diet
Nutrition can affect drug metabolism by altering the pool of substances needed for phase II enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Can environmental pollutants affect the P450 enzyme function?

A

Yes, like cigarette smoke and petroleum products

21
Q

Can liver disease significantly slow drug metabolism and result in higher concentrations of active drug forms and toxic drug effects?

A

Yes
P450 and other liver enzymes are crucial for drug metabolism

22
Q

What can liver disease include?

A

Hepatitis
Cirrhosis (scar tissue) of the liver (often caused by chronic alcoholism or chronic infection)
Cancer
Fatty infiltration of the liver
Hemochromatosis (iron overload – body absorbs too much iron from food and stores it. Can be genetic)

23
Q

Should drug dosage be lowered for patients with liver disease?

A

Yes

24
Q

Can comorbid cardiac and liver disease also affect drug metabolism?

A

Yes
With cardiac disease, blood flow is compromised leading to suprathreshold levels of drugs in patients with heart failure

25
Q

Do thyroid hormones regulate the body’s basal metabolic rate and, therefore, drug metabolism?

A

Yes
Hyperthyroidism can increase the metabolic rate of some drugs
Hypothyroidism can decrease the metabolic rate of other drugs

26
Q

Are most drugs eliminated from the kidneys?

A

Yes
Accumulation and toxicity can develop rapidly if dosages are not adjusted in patients with impaired renal function
In addition to a reduced glomerular filtration rate, patients with renal disease often have alterations in pharmacokinetics such as drug bioavailability, protein binding, and volume distribution

27
Q

What is compliance?

A

The degree to which a patient’s behavior matches medical advice
Noncompliance, therefore, is any behavior that does not follow medical advice

28
Q

What is compliance defined as in pharmacology?

A

The degree of correlation of the actual dosing history with the prescribed medical therapy
It is the amount of drug taken vs. the amount of drug prescribed

29
Q

Does medical noncompliance increase the incidence of chronic disease?

A

Yes
It also affects audiologists, for e.g., when patients do not regularly wear HAs or carry out a tinnitus or vestibular treatment regimen

30
Q

How does the world health organization define noncompliance?

A

A multidimensional phenomenon determined by the interplay of five sets of factors (patient related, condition related, therapy related, health system factors, and social factors)

31
Q

How often is noncompliance?

A

It can range from 20% to 80% depending on the treatment
On average, patients follow the advice of healthcare providers about 50% the time
Compliance can even lower for complicated treatments or regimens involving lifestyle changes

32
Q

What are the types of noncompliance?

A

Prolonged intervals between dose administrations (lapses of greater or equal to 3 days are called drug holidays)
Non-persistence (cessation of medication) - ultimate expression of noncompliance
White coat compliance (improved compliance around doctors’ visits, can cause diagnostic and therapeutic confusion)

33
Q

Can parents and caregivers affect compliance?

A

Yes
Family’s belief regarding susceptibility to disease, disease severity, and benefits of treatment play a role in compliance
Parental anxiety if activity is restricted due to medication, affects compliance and results in under or overdosing

34
Q

Can type of illness or disease affect compliance?

A

Yes
Rate of compliance for acute illness, including otitis media is about 50%, which is poor
Therapy for chronic diseases shows a slightly better rate of compliance than acute diseases

35
Q

Can intellectual status affect compliance?

A

Yes
Memory problems (forgetting to take medication or regimen)
Ability to follow and understand directions
Diminished cognitive status
Difficulty with task organization
Fear of needles (belonephobia and trypanophobia)

36
Q

Can physical status affect compliance?

A

Yes
Visual problems (cannot read labels/instructions)
Musculoskeletal problems (cannot open bottles)
Depression
Chronic and/or comorbid medical conditions
Difficulty swallowing

37
Q

What are some other factors that can affect compliance?

A

Denial of the illness (including hearing loss)
Stopping or reducing the frequency of drug administration
Long-term compliance (boredom)
Misunderstanding or never receiving directions for use
Literacy issues (inability to read labels/directions)
Managing drugs becomes stressful for many older adults
Lack of confidence in the drug’s effectiveness
Improvement of symptoms or not
Concerns about potential side effects
Apathy (not getting prescriptions filled)
Cost of medications (e.g., choosing between food and medication)
Access to medical care/pharmacy
Transport issues
Socioeconomic status

38
Q

How do you improve compliance?

A

Education is key (Education of patients, families, and care givers and educating health care providers to recognize barriers to compliance and address them)
Important to remember that if the patient cannot see/hear clearly or remember instructions, frustration and errors with the treatment regimen will set in
Recognize and address dexterity issues if present
Providing older patients with clear and concise written instructions in large print
Improving communication between multiple providers

39
Q

What is polypharmacy?

A

taking 5 or more medications at the same time
More common in older adults and younger people with chronic medical conditions

40
Q

Does polypharmacy increase the risk of adverse drug-drug or drug-disease interactions?

A

Yes
Also increases the risk of prescription cascade (side effects of drug interactions are misdiagnosed as symptoms of a new medical condition)

41
Q

Has the use of OTCs increased in the past decade?

A

Yes, especially among the elderly who are already at risk of polypharmacy
Less than half of patients discuss the use of OTCs with their medical providers
There are safety issues regarding their use, including risks for herb-drug interactions

42
Q

When does polypharmacy become problematic?

A

When patients are prescribed too many medications by multiple healthcare providers working independently of each other
Optimizing medication regimen is one of the critical elements in comprehensive geriatric care

43
Q

How many prescription medications does the average person >50 years old take?

A

At least 4

44
Q

What are the 4 basic mechanisms of drug interactions?

A

Drugs having similar effects (additive, synergistic, potentiation of each other)
Metabolic effects (altered CYP enzymes resulting in enzyme induction or inhibition)
Absorption effects (altered pH, affecting binding of drugs in the stomach)
Displacement of plasma proteins (more active or free drug in circulation)

45
Q

What are some examples of adverse drug interactions?

A

Aminoglycoside antibiotics and furosemide (diuretic)
Potentiate the ototoxic and nephrotoxic effects of each other when administered IV together relative to when taken alone

46
Q

What kind of drug interactions are cardiovascular drugs involved in?

A

Drug-drug interactions
Leading to adverse drug interactions such as neuropsychological (e.g., delirium), acute renal failure, and hypotension

47
Q

What are the most dangerous drug interactions?

A

Medications that affect the CNS
Alter the ability to function
Decreased independence
Ability to drive safely
Ability to ambulate safely without falling

48
Q

Does medicare now require health care providers to ask about drugs being taken by every patient (prescription and OTC)?

A

Yes